Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bellicum Pharmaceuticals (BLCM)
OTHER OTC:BLCM
Holding BLCM?
Track your performance easily
BLCM Stock Chart & Stats
Day’s Range$0.07 - $0.09
52-Week Range― - ―
Previous Close$0.08
Volume6.06K
Average Volume (3M)N/A
Market Cap
$889.60K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bellicum Pharmaceuticals News
PremiumCompany Announcements
Bellicum Pharmaceuticals Appoints New CEO During Dissolution
PremiumCompany Announcements
Bellicum Pharmaceuticals Finalizes Sale and Approves Dissolution
PremiumCompany Announcements
Bellicum Pharmaceuticals Asset Sale and Dissolution Vote Adjourned
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLCM FAQ
What was Bellicum Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Bellicum Pharmaceuticals’s market cap?
Currently, no data Available
When is Bellicum Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bellicum Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Bellicum Pharmaceuticals overvalued?
According to Wall Street analysts Bellicum Pharmaceuticals’s price is currently Overvalued.
Does Bellicum Pharmaceuticals pay dividends?
Bellicum Pharmaceuticals does not currently pay dividends.
What is Bellicum Pharmaceuticals’s EPS estimate?
Bellicum Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bellicum Pharmaceuticals have?
Currently, no data Available
What happened to Bellicum Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bellicum Pharmaceuticals?
Among the largest hedge funds holding Bellicum Pharmaceuticals’s share is Baker Bros Advisors LP. It holds Bellicum Pharmaceuticals’s shares valued at N/A.
---
Bellicum Pharmaceuticals Stock Smart Score
Company Description
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.
---
BLCM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---